CHINA PHARMACEUTICALS INC Operating Income
CHINA PHARMACEUTICALS INC reported Operating Income of -$815.61 thousand for the 3-month period ending 2012-06-30, per its 10-Q/A filed 2012-08-27.
Discontinued › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2012-08-27
- CHINA PHARMACEUTICALS INC operating income (loss) for the quarter ending 2012-06-30 was -$815.61K.
- CHINA PHARMACEUTICALS INC operating income (loss) for the quarter ending 2012-03-31 was -$407.90K, a 112.20% decline year-over-year.
- CHINA PHARMACEUTICALS INC operating income (loss) for the quarter ending 2011-12-31 was -$6.80M.
- CHINA PHARMACEUTICALS INC operating income (loss) for the quarter ending 2011-09-30 was $682.34K, a 47.66% decline year-over-year.
- CHINA PHARMACEUTICALS INC operating income (loss) for fiscal 2011 was -$3.71M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2012-06-30 | -$815.61K 10-Q/A · filed 2012-08-27 | -$1.22M 10-Q/A · filed 2012-08-27 | -$8.03M derived: sum of 3 quarters · filed 2012-08-27 | -$7.34M derived: sum of 4 quarters · filed 2012-08-27 |
| 2012-03-31 | -$407.90K 10-Q · filed 2012-05-21 | -$7.21M derived: sum of 2 quarters · filed 2012-05-21 | -$6.53M derived: sum of 3 quarters · filed 2012-05-21 | -$7.46M derived: sum of 4 quarters · filed 2012-08-27 |
| 2011-12-31 | -$6.80M derived: 10-K 12 month − 10-Q 9 month · filed 2012-05-07 | -$6.12M derived: sum of 2 quarters · filed 2012-05-07 | -$7.06M derived: sum of 3 quarters · filed 2012-08-27 | -$3.71M 10-K · filed 2012-05-07 |
| 2011-09-30 | $682.34K 10-Q · filed 2011-11-21 | -$251.68K derived: sum of 2 quarters · filed 2012-08-27 | $3.09M 10-Q · filed 2011-11-21 | |
| 2011-06-30 | -$934.02K 10-Q/A · filed 2012-08-27 | $2.41M 10-Q/A · filed 2012-08-27 | ||
| 2011-03-31 | $3.34M 10-Q · filed 2012-05-21 | |||
| 2010-09-30 | $1.30M 10-Q · filed 2011-11-21 | $7.66M derived: sum of 2 quarters · filed 2011-11-21 | $8.87M 10-Q · filed 2011-11-21 | |
| 2010-06-30 | $6.36M 10-Q/A · filed 2011-09-16 | $7.57M 10-Q/A · filed 2011-09-16 |